Another Biotech Bites the Dust as Cambridge's Raze Shuts Down Post author:Sam Post published:December 13, 2017 Post category:BioPharma Reportedly, Raze Therapeutics, a biotech launched in 2014, has closed its doors. Source: BioSpace You Might Also Like Bristol-Myers, Johnson & Johnson Get in on Europeon Biotech Fund's $95M Raise October 30, 2017 ProMetic Life Sci Reports Its 2016 Fourth Quarter And Year End Highlights And Financial Results March 30, 2017 Teva Continues Restructuring With 46 Cuts in Pennsylvania February 7, 2018
ProMetic Life Sci Reports Its 2016 Fourth Quarter And Year End Highlights And Financial Results March 30, 2017
